{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:18:51Z","timestamp":1791724731400,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG050431"],"award-info":[{"award-number":["AG050431"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS108025"],"award-info":[{"award-number":["NS108025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.nbd.2021.105318","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T02:36:37Z","timestamp":1614134197000},"page":"105318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate"],"prefix":"10.1016","volume":"153","author":[{"given":"Debashis","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh Kumar","family":"Paidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalipada","family":"Pahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105318_bb0005","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.neuroimage.2012.01.141","article-title":"Spatiotemporal mapping of brain atrophy in mouse models of Huntington\u2019s disease using longitudinal in vivo magnetic resonance imaging","volume":"60","author":"Aggarwal","year":"2012","journal-title":"Neuroimage."},{"key":"10.1016\/j.nbd.2021.105318_bb0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/nmt-2016-0008","article-title":"The global prevalence of Huntington\u2019s disease: a systematic review and discussion","volume":"6","author":"Baig","year":"2016","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.nbd.2021.105318_bb0015","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.nbd.2021.105318_bb0020","first-page":"250","article-title":"Huntington\u2019s chorea","volume":"59","author":"Beighton","year":"1981","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.nbd.2021.105318_bb0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2021.105318_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4049\/jimmunol.179.1.275","article-title":"Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis","volume":"179","author":"Brahmachari","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2021.105318_bb0035","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1523\/JNEUROSCI.5480-05.2006","article-title":"Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide","volume":"26","author":"Brahmachari","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105318_bb0040","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.4049\/jimmunol.0803336","article-title":"Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses","volume":"183","author":"Brahmachari","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2021.105318_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/bj1180047","article-title":"The fate of benzoic acid in various species","volume":"118","author":"Bridges","year":"1970","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2021.105318_bb0050","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2237","article-title":"Evaluation of muscle performance in mice by treadmill exhaustion test and whole-limb grip strength assay","volume":"7","author":"Castro","year":"2017","journal-title":"Bio Protoc."},{"key":"10.1016\/j.nbd.2021.105318_bb0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105318_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cns.12189","article-title":"Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease","volume":"20","author":"Chakraborty","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2021.105318_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells5010012","article-title":"The regulation of NF-kappaB subunits by phosphorylation","volume":"5","author":"Christian","year":"2016","journal-title":"Cells."},{"key":"10.1016\/j.nbd.2021.105318_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jnen\/nly123","article-title":"Selective vulnerability of basal ganglia: insights into the mechanisms of bilateral striatal necrosis","volume":"78","author":"Cirillo","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105318_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington\u2019s disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2021.105318_bb0080","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12035-016-0328-y","article-title":"Low levels of Prohibitin in Substantia Nigra makes dopaminergic neurons vulnerable in Parkinson\u2019s disease","volume":"55","author":"Dutta","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105318_bb0085","doi-asserted-by":"crossref","first-page":"104575","DOI":"10.1016\/j.nbd.2019.104575","article-title":"RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson\u2019s disease","volume":"132","author":"Dutta","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105318_bb0090","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-kappaB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2021.105318_bb0095","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105318_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbrc.2006.01.136","article-title":"Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction","volume":"342","author":"Goswami","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2021.105318_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archneur.62.1.46","article-title":"Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways","volume":"62","author":"Gunawardena","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2021.105318_bb0110","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11481-013-9447-7","article-title":"Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders","volume":"8","author":"Jana","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2021.105318_bb0115","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/18715273113126660170","article-title":"A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases","volume":"12","author":"Kaushik","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2021.105318_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11481-014-9552-2","article-title":"Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Khasnavis","year":"2014","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2021.105318_bb0125","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105318_bb0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4143\/crt.2013.45.4.313","article-title":"Effects of polymorphisms of innate immunity genes and environmental factors on the risk of noncardia gastric cancer","volume":"45","author":"Kim","year":"2013","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.nbd.2021.105318_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.intimp.2013.12.016","article-title":"Rotundarpene inhibits toll-like receptor 2 activation-induced production of inflammatory mediators in keratinocytes by suppressing the Akt and NF-kappaB pathways","volume":"18","author":"Kim","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.nbd.2021.105318_bb0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0006-8993(00)01948-X","article-title":"3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington\u2019s disease","volume":"858","author":"La Fontaine","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2021.105318_bb0145","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease","volume":"285","author":"Landles","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2021.105318_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103609","article-title":"Early reactive A1 astrocytes induction by the neurotoxin 3-Nitropropionic acid in rat brain","volume":"21","author":"Lopez-Sanchez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2021.105318_bb0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington\u2019s disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105318_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130398","article-title":"Cinnamon and its metabolite sodium benzoate attenuate the activation of p21rac and protect memory and learning in an animal model of Alzheimer\u2019s disease","volume":"10","author":"Modi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105318_bb0165","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000488","article-title":"Glyceryl tribenzoate: a flavoring ingredient, inhibits the adoptive transfer of experimental allergic encephalomyelitis via TGF-beta: implications for multiple sclerosis therapy","volume":"8","author":"Mondal","year":"2017","journal-title":"J. Clin. Cell Immunol."},{"key":"10.1016\/j.nbd.2021.105318_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3892\/br.2013.53","article-title":"Beta-2 microglobulin is unsuitable as an internal reference gene for the analysis of gene expression in human colorectal cancer","volume":"1","author":"Nihon-Yanagi","year":"2013","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.nbd.2021.105318_bb0175","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1172\/JCI119812","article-title":"Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages","volume":"100","author":"Pahan","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2021.105318_bb0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","article-title":"Mitochondrial NAD+-linked state 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington\u2019s disease","volume":"104","author":"Pandey","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2021.105318_bb0185","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuint.2009.04.013","article-title":"Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington\u2019s disease in rats","volume":"55","author":"Pandey","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2021.105318_bb0190","article-title":"Reduction of Lewy body pathology by oral cinnamon","author":"Raha","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2021.105318_bb0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.nbd.2021.105318_bb0200","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1074\/jbc.M600236200","article-title":"Up-regulation of microglial CD11b expression by nitric oxide","volume":"281","author":"Roy","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2021.105318_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jmg.36.4.265","article-title":"Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts?","volume":"36","author":"Rubinsztein","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2021.105318_bb0210","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/ars.2006.8.929","article-title":"Regulation of inducible nitric oxide synthase gene in glial cells","volume":"8","author":"Saha","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2021.105318_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105318_bb0220","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2021.105318_bb0225","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0272-0590(84)90208-2","article-title":"Lack of tumorigenicity of sodium benzoate in mice","volume":"4","author":"Toth","year":"1984","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.nbd.2021.105318_bb0230","doi-asserted-by":"crossref","first-page":"571185","DOI":"10.3389\/fnagi.2020.571185","article-title":"On the right track to treat movement disorders: promising therapeutic approaches for Parkinson\u2019s and Huntington\u2019s disease","volume":"12","author":"Troncoso-Escudero","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2021.105318_bb0235","doi-asserted-by":"crossref","first-page":"577380","DOI":"10.1016\/j.jneuroim.2020.577380","article-title":"Inflammation in Huntington\u2019s disease: a few new twists on an old tale","volume":"348","author":"Valadao","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2021.105318_bb0240","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington\u2019s disease: a genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612100067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612100067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:53:52Z","timestamp":1778576032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612100067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"alternative-id":["S096999612100067X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105318","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105318"}}